Segment Information

12 Months Ended

Dec. 31, 2021

Segment Reporting, Measurement Disclosures [Abstract]

Segment Information

SEGMENT INFORMATION

The Company operates and reports its results in three separate business segments consisting of the Life Sciences, Diagnostics and Environmental & Applied Solutions segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income and expense, loss on early extinguishment of borrowings, interest and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. The identifiable assets by segment are those used in each segment’s operations. Intersegment amounts are not significant and are eliminated to arrive at consolidated totals.

Detailed segment data for the years ended December 31 is as follows ($ in millions):

	2021		2020		2019
Sales:
Life Sciences	$	14,958	$	10,576	$	6,951
Diagnostics	9,844		7,403		6,561
Environmental & Applied Solutions	4,651		4,305		4,399
Total	$	29,453	$	22,284	$	17,911
Operating profit:
Life Sciences	$	4,367	$	2,054	$	1,401
Diagnostics	2,313		1,538		1,134
Environmental & Applied Solutions	1,054		979		1,052
Other	(269)		(340)		(318)
Total	$	7,465	$	4,231	$	3,269
Depreciation and amortization of intangible assets:
Life Sciences	$	1,441	$	1,053	$	487
Diagnostics	614		602		582
Environmental & Applied Solutions	106		110		111
Other	7		10		9
Total	$	2,168	$	1,775	$	1,189

The following table presents additional detailed segment data for the years ended December 31 ($ in millions):

	2021		2020		2019
Identifiable assets:
Life Sciences	$	57,886	$	48,919	$	22,381
Diagnostics	15,054		15,042		14,442
Environmental & Applied Solutions	4,882		5,083		4,882
Other	5,362		7,117		20,377
Total	$	83,184	$	76,161	$	62,082
Capital expenditures, gross:
Life Sciences	$	595	$	306	$	143
Diagnostics	644		447		435
Environmental & Applied Solutions	54		36		54
Other	1		2		4
Total	$	1,294	$	791	$	636

Operations in Geographical Areas:

	Year Ended December 31
($ in millions)	2021		2020		2019
Sales:
United States	$	11,283	$	8,616	$	6,660
China	3,975		2,688		2,308
Germany	1,482		1,238		1,013
All other (each country individually less than 5% of total sales)	12,713		9,742		7,930
Total	$	29,453	$	22,284	$	17,911
Property, plant and equipment, net:
United States	$	1,799	$	1,317	$	1,077
Sweden	513		553		32
United Kingdom	260		214		163
Germany	223		207		163
All other (each country individually less than 5% of total property, plant and equipment, net)	995		971		867
Total	$	3,790	$	3,262	$	2,302

Sales by Major Product Group:

	Year Ended December 31
($ in millions)	2021		2020		2019
Analytical and physical instrumentation	$	2,620	$	2,443	$	2,464
Research and medical products	24,802		17,979		13,512
Product identification	2,031		1,862		1,935
Total	$	29,453	$	22,284	$	17,911